These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1182 related articles for article (PubMed ID: 22849944)
1. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma]. Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Grazioli L; Bondioni MP; Haradome H; Motosugi U; Tinti R; Frittoli B; Gambarini S; Donato F; Colagrande S Radiology; 2012 Feb; 262(2):520-9. PubMed ID: 22282184 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890 [TBL] [Abstract][Full Text] [Related]
5. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia. Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977 [TBL] [Abstract][Full Text] [Related]
6. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy. Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma. Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759 [TBL] [Abstract][Full Text] [Related]
8. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959 [TBL] [Abstract][Full Text] [Related]
11. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994 [TBL] [Abstract][Full Text] [Related]
12. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI. Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review. Guo Y; Li W; Cai W; Zhang Y; Fang Y; Hong G Int J Med Sci; 2017; 14(7):668-674. PubMed ID: 28824299 [No Abstract] [Full Text] [Related]
14. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Suh CH; Kim KW; Kim GY; Shin YM; Kim PN; Park SH Eur Radiol; 2015 Apr; 25(4):950-60. PubMed ID: 25537979 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333 [TBL] [Abstract][Full Text] [Related]
17. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Roux M; Pigneur F; Baranes L; Calderaro J; Chiaradia M; Decaens T; Kastahian S; Charles-Nelson A; Tselikas L; Costentin C; Laurent A; Azoulay D; Mallat A; Rahmouni A; Luciani A Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059 [TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
19. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]